Drugs targeting the IGF1R and apoptosis pathways that associated with the reduction of lactate content and antitumor effect (23, 24) were negatively correlated with the lactate score, suggesting a potential link between lactate-related molecules and chemoresistance mechanisms in DLBCL. This evidence concerns the gene IGF1R and diffuse large B-cell lymphoma.